David A. Siegel Novartis Ag Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Novartis Ag stock. As of the latest transaction made, Two Sigma Advisers, LP holds 3,700 shares of NVS stock, worth $381,433. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,700

Previous 3,900 5.13%

Holding current value

$381,433

Previous $415,000 2.41%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $21,226 - $24,178	-200 Reduced 5.13%	3,700 $425,000
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $361,023 - $418,743	3,900 New	3,900 $415,000
Q3 2023 Nov 14, 2023	SELL	$94.73 - $105.13 $1.5 Million - $1.66 Million	-15,800 Reduced 64.75%	8,600 $875,000
Q2 2023 Aug 14, 2023	SELL	$92.52 - $104.91 $47 Million - $53.3 Million	-508,000 Reduced 95.42%	24,400 $2.46 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $86 Million - $99.7 Million	-1,074,100 Reduced 66.86%	532,400 $49 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $55.1 Million - $67.5 Million	-729,300 Reduced 31.22%	1,606,500 $146 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $17.7 Million - $20.7 Million	-237,400 Reduced 9.23%	2,335,800 $178 Million
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $29.3 Million - $34.1 Million	-363,500 Reduced 12.38%	2,573,200 $218 Million
Q1 2022 May 16, 2022	BUY	$80.11 - $90.62 $5.37 Million - $6.07 Million	67,000 Added 2.33%	2,936,700 $258 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $61.6 Million - $68.1 Million	772,900 Added 36.86%	2,869,700 $251 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $16.7 Million - $19.4 Million	203,700 Added 10.76%	2,096,800 $171 Million
Q2 2021 Aug 16, 2021	BUY	$85.24 - $94.15 $161 Million - $178 Million	1,893,100 New	1,893,100 $173 Million
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $3.18 Million - $3.58 Million	-39,300 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $2.78 Million - $3.89 Million	39,300 New	39,300 $3.24 Million
Q4 2019 Feb 14, 2020	SELL	$84.35 - $95.37 $4.45 Million - $5.03 Million	-52,700 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $3.68 Million - $4.05 Million	43,000 Added 443.3%	52,700 $4.58 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $731,380 - $900,160	9,700 New	9,700 $886,000
Q4 2018 Feb 14, 2019	SELL	$73.66 - $82.02 $427,228 - $475,716	-5,800 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $12.2 Million - $14.1 Million	-182,200 Reduced 96.91%	5,800 $500,000
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $10.7 Million - $12.1 Million	165,300 Added 728.19%	188,000 $14.2 Million
Q1 2018 May 15, 2018	BUY	$70.39 - $84.15 $1.6 Million - $1.91 Million	22,700 New	22,700 $1.84 Million

Others Institutions Holding NVS

# of Institutions

1,434

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account